Windlas Biotech's new GMP-certified injectable facility expands manufacturing capabilities for global pharmaceutical markets.

Considering its robust fundamentals, strategic positioning under the BioE3 policy, and strong growth potential, we believe ...

WuXi AppTec, the Shanghai-based biotech giant, has sold its South Philly-based WuXi Advanced Therapies contract manufacturing ...

Legend Biotech is a commercial-stage biotech company specializing in innovative cell therapies. Click here to find out why I ...

The biotech industry is booming thanks to the rising demand for personalized medicine, investment in innovations, and ongoing ...

Despite a more widespread shift toward product recyclability, these types of linear systems are still especially prevalent in the plastics industry. Typical product life cycles range from short-lived, ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Windlas Biotech added 1.76% to Rs 1,033.15 after the company announced that its new state-of-the-art injectable facility has received Good Manufacturing Practices (GMP) certification.

The biotechnology market experiences significant growth, fueled by advancements in genetic therapies and supportive global ...

Wall Street did not react favorably to the plan. Windtree stock dropped to a new low of 25 cents per share Wednesday morning ...

Anneo Biotech has been awarded the prestigious Outlook Business Spotlight - Entity Awards 2024 for Best Emerging BioTech ...

Kingswood Capital Partners, LLC ("Kingswood") acted as the sole book-running manager for the Offering. Hunter Taubman Fischer ...